Tag: economics

Blog Posts (6)

April 9, 2014

US jury orders Takeda, Eli Lilly to pay $9 billion in damages over Actos

[FirstWordPharma] A US jury ordered Takeda and Eli Lilly to pay a combined $9 billion in punitive damages after finding that the companies concealed the cancer risks associated with the diabetes therapy Actos (pioglitazone). The jury also awarded compensatory damages to the plaintiff of nearly $1.5 million in the first federal lawsuit related to the […]
April 2, 2014

Med-school officials risk conflicts by serving on pharma boards

[FiercePharma] Much has been made recently over the potential conflicts of interest that arise when doctors take speaking fees from pharma companies. But as a new report suggests, some companies are shelling out a whole lot more to keep medical school and hospital leaders on their boards–where conflicts-of-interest could be much further-reaching. As The Wall […]
March 24, 2014

AIDS Group To Pharma CEO: Lower Your Prices Or Lower Your Pay

[Ed Silverman, WSJ]  Outraged by the prices that Gilead Sciences charges for some of its medicines, an AIDS advocacy organization has succeeded in placing what is being called a unique resolution before the drug company’s shareholders. The proposal ties compensation for chief executive John Martin to wider access to the drug maker’s popular roster of HIV […]
April 29, 2008

Can you buy changes in health behaviors?

By Stuart Rennie

And the girl behind the counter has a tattooed tear
One for every year he’s away she said
Such a crumbling beauty,
Ach there’s nothing wrong with her
That a hundred dollars won’t fix

Those are lyrics from Tom Waits’ song ’9th and Hennepin.’ They slipped involuntarily into my consciousness when I read about a World Bank study that is being planned in Tanzania.…

April 22, 2008

Corn, oil and hunger

A trio of recent dots from the news stream that practically yell out to be connected:

+ The UN reported this week that rising food prices are pushing 100 million people even deeper into hunger.…

October 4, 2007

Talking about the consequences of chronic disease

The Milken Institute released a report this week totaling the cost of preventable chronic disease in the US. The report’s tally for 2003 was $1.3 trillion.* And when you float a number like that, people tend to notice.…